Efficacy of Different Leuprolide Administration Schedules in Premenopausal Breast Cancer: AÂ Retrospective Review

Leuprolide acetate depot administered every 3 months is as efficacious and tolerable as a monthly injection in combination with an aromatase inhibitor for premenopausal patients with hormone receptor-positive breast cancer.